Effect of self-administered intraperitoneal bemiparin on peritoneal transport and ultrafiltration capacity in peritoneal dialysis patients with membrane dysfunction. A randomized, multi-centre open clinical trial.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Volumn 27, Issue 5, 2012, Pages 2051-2058

  Del Peso, Gloria ^a   Bajo, M Auxiliadora ^b   Fontán, Miguel Perez ^b   Martínez, Javier ^b   Marrón, Belen ^b   Selgas, Rafael ^b   Group of Study on Bemidextrin, ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BEMIPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY DISEASE; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; ULTRAFILTRATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, INTRAPERITONEAL; KIDNEY DISEASES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; RISK FACTORS; SELF ADMINISTRATION; ULTRAFILTRATION;

EID: 84871883057     PISSN: None     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr546     Document Type: Article

References (0)